Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zepp Health (ZEPP) Cash & Equivalents (2016 - 2024)

Zepp Health has reported Cash & Equivalents over the past 10 years, most recently at $91.1 million for Q4 2024.

  • Quarterly results put Cash & Equivalents at $91.1 million for Q4 2024, down 30.91% from a year ago — trailing twelve months through Dec 2024 was $91.1 million (down 30.91% YoY), and the annual figure for FY2024 was $91.1 million, down 31.87%.
  • Cash & Equivalents for Q4 2024 was $91.1 million at Zepp Health, down from $131.8 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for ZEPP hit a ceiling of $343.0 million in Q4 2020 and a floor of $91.1 million in Q4 2024.
  • Median Cash & Equivalents over the past 5 years was $131.8 million (2023), compared with a mean of $184.1 million.
  • Biggest five-year swings in Cash & Equivalents: skyrocketed 34.09% in 2020 and later tumbled 45.72% in 2022.
  • Zepp Health's Cash & Equivalents stood at $343.0 million in 2020, then crashed by 33.04% to $229.7 million in 2021, then tumbled by 45.72% to $124.7 million in 2022, then rose by 5.73% to $131.8 million in 2023, then tumbled by 30.91% to $91.1 million in 2024.
  • The last three reported values for Cash & Equivalents were $91.1 million (Q4 2024), $131.8 million (Q4 2023), and $124.7 million (Q4 2022) per Business Quant data.